http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY®
-
Knight Partners with Debiopharm for the Commercialization of Trelstar® in Canada
-
Knight Partners With Debiopharm for the Commercialization of Trelstar® in Canada
-
Knight and TherapeuticsMD Announce Filing of New Drug Submission for BIJUVA® in Canada
-
Knight and TherapeuticsMD Announce Filing of New Drug Submission for Bijuva® in Canada
-
Knight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta™ in Canada
-
Knight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta™ in Canada
-
TherapeuticsMD Announces Third Quarter 2018 Financial Results
-
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada
-
Advaxis Announces Licensing Agreement With Knight Therapeutics and Raises $25 Million Through Direct Investments From Knight and Sectoral Asset Management
-
Advaxis Announces Licensing Agreement With Knight Therapeutics and Raises $25 Million Through Direct Investments From Knight and Sectoral Asset Management
